Peregrine Asset Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.14M | Buy |
|
|||||
|
2025
Q2 | $2.18M | Buy |
|
|||||
|
2025
Q1 | $2.31M | Sell |
|
|||||
|
2024
Q4 | $2.18M | Sell |
|
|||||
|
2024
Q3 | $5.08M | Sell |
|
|||||
|
2024
Q2 | $6.88M | Sell |
|
|||||
|
2024
Q1 | $7.49M | Buy |
|
|||||
|
2023
Q4 | $4.73M | Sell |
|
|||||
|
2023
Q3 | $5.86M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q4 | $414K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $343K | Sell |
|
|||||
|
2020
Q1 | $586K | Buy |
|